XML 92 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
6 Months Ended 12 Months Ended 24 Months Ended 6 Months Ended 12 Months Ended 24 Months Ended 12 Months Ended 24 Months Ended
Jan. 31, 2014
Jan. 31, 2013
Jul. 31, 2013
Jul. 31, 2012
Dec. 31, 2013
Inventergy Inc [Member]
Dec. 31, 2012
Inventergy Inc [Member]
Dec. 31, 2013
Inventergy Inc [Member]
Jan. 31, 2014
Cortelco Systems Holding Corp [Member]
Jan. 31, 2013
Cortelco Systems Holding Corp [Member]
Jul. 31, 2013
Cortelco Systems Holding Corp [Member]
Jul. 31, 2012
Cortelco Systems Holding Corp [Member]
Dec. 31, 2013
Series A One Preferred Stock [Member]
Inventergy Inc [Member]
Dec. 31, 2013
Series A One Preferred Stock [Member]
Inventergy Inc [Member]
Dec. 31, 2013
Series A Two Preferred Stock [Member]
Inventergy Inc [Member]
Dec. 31, 2013
Series A Two Preferred Stock [Member]
Inventergy Inc [Member]
CASH FLOWS FROM OPERATING ACTIVITIES:                              
Net income (loss) $ (1,210,000) $ 229,000 $ 222,000 $ 512,000 $ (4,731,072) $ (12,783) $ (4,743,855) $ (445,000) $ 461,000 $ 1,184,000 $ 679,000        
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:                              
Depreciation and amortization 81,000 43,000 134,000 105,000   0   79,000 41,000 132,000 97,000        
Provision for (recovery of) doubtful trade accounts receivable (23,000) 23,000 23,000 46,000   0                  
Imputed interest expense on notes payable 344,000 (281,000) (306,000) 158,000   0   344,000 (281,000) (306,000) 158,000        
Impairment of investment (394,000) 0       0   (394,000) 0            
Provision for obsolete inventory     40,000 119,000   0                  
Deferred income taxes     0 0   0   (153,000) 0 20,000 (1,000)        
Other     0 (5,000)   0                  
Loss (gain) on disposal of fixed assets     3,000 (2,000)   0                  
Decrease in fair value of derivative liabilities         539,467 0 539,467         0   0  
Amortization of discount on notes payable         353,009 0 353,009         0   0  
Amortization of patents         293,176    293,176         0   0  
Loss on sale of discontinued operations (76,000) (127,000) 286,000 0                       
Stock-based compensation expense     4,000 7,000 1,872,104    1,872,104         0   0  
Changes in net assets and liabilities:                              
Trade accounts receivable (198,000) 381,000 (126,000) 759,000        (331,000) 161,000 (193,000) 876,000        
Inventories 1,144,000 (449,000) (191,000) 136,000        1,196,000 (635,000) (184,000) (8,000)        
Prepaid and other assets (20,000) 82,000 174,000 (155,000) (73,207)   (73,207) (2,000) 93,000 176,000 (266,000) 0   0  
Trade accounts payable (452,000) 149,000 238,000 (601,000)        (420,000) 161,000 109,000 (573,000)        
Accrued expenses and other (32,000) (421,000) (388,000) (77,000)   12,783   37,000 (270,000) (260,000) (7,000)        
Deposits and other assets         (20,399)    (20,399)         0   0  
Accounts payable         602,564    615,347         0   0  
Accrued interest on notes payable         6,935    6,935         0   0  
Net cash provided by (used in) operating activities 28,000 (244,000) 113,000 1,002,000 (2,236,357) 0 (2,236,357) 699,000 (269,000) 678,000 955,000 0   0  
CASH FLOWS FROM INVESTING ACTIVITIES:                              
Purchases of property and equipment (73,000) (160,000) (288,000) (232,000)        (73,000) (160,000) (288,000) (121,000)        
Purchase of patents         (9,455,585)    (9,455,585)         0   0  
Net cash used in investing activities (73,000) (160,000) (288,000) (232,000) (9,455,585)    (9,455,585) (73,000) (160,000) (288,000) (121,000) 0   0  
CASH FLOWS FROM FINANCING ACTIVITIES:                              
Repayment of note payable (122,000) (191,000) (210,000) (168,000)        (122,000) (191,000) (210,000) (168,000)        
Borrowing on lines of credit 250,000 0            250,000 0            
Net distributions from (to) eOn Communications Corporation               (646,000) 82,000 (390,000) 354,000        
Proceeds from sale of treasury stock     1,000 0                       
Proceeds from employee stock purchase plan 13,000 0 0 18,000                       
Proceeds from issuance of common stock         3,612,100   3,612,100                
Proceeds from issuance of redeemable convertible preferred stock 2,750,000 0                    50,000 50,000 1,498,526 1,498,526
Proceeds from issuance of notes payable         4,950,000   4,950,000         0   0  
Proceeds from issuance of short-term notes payable, related party         3,100,000   3,100,000         0   0  
Restricted cash (2,750,000) 0                           
Net cash provided by (used in) financing activities 141,000 (191,000) (209,000) (150,000) 13,210,626   13,210,626 (518,000) (109,000) (600,000) 186,000 0   0  
Net increase (decrease) in cash and cash equivalents 96,000 (595,000) (384,000) 620,000 1,518,684 0 1,518,684 108,000 (538,000) (210,000) 1,020,000 0   0  
Cash and cash equivalents, beginning of period 1,778,000 2,162,000 2,162,000 1,542,000 0 0 0 1,649,000 1,859,000 1,859,000 839,000 0   0  
Cash and cash equivalents, end of period 1,874,000 1,567,000 1,778,000 2,162,000 1,518,684 0 1,518,684 1,757,000 1,321,000 1,649,000 1,859,000 0 0 0 0
Supplemental cash flow information:                              
Income taxes paid     12,000 60,000                       
Cash paid for interest         5,898   5,898         0   0  
Non cash investing and financing activity:                              
Note payable for purchase of equipment     0 111,000   0       0 111,000        
Receivable from sale of business     48,000 0                       
Supplemental disclosures of non-cash investing and financing activities                              
Convert outstanding LLC accrued liabilities to member contribution, January 2013         12,783    12,783         0   0  
Allocation of fair value from Series A-2 redeemable convertible preferred stock to Series A-1 redeemable convertible preferred stock (See Note 6)         865,985    865,985         0   0  
Allocation of fair value from notes payable to Series A-1 redeemable convertible preferred stock (See Note 5)         2,392,889    2,392,889         0   0  
Fair value of notes payable redemption derivative liability         582,903    582,903         0   0  
Fair value of Series A-1 redeemable convertible preferred stock anti-dilution derivative liability         548,465    548,465         0   0  
Accrued guaranteed payments and deferred expenses associated with purchased patent assets         $ 13,510,178   $ 13,510,178         $ 0   $ 0